Dupont Capital Management Corp Catalyst Pharmaceuticals, Inc. Transaction History

Dupont Capital Management Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$12.25 - $19.5 $131,124 - $208,728	-10,704 Reduced 58.81%	7,498 $0
Q3 2022 Oct 31, 2022	SELL	$7.06 - $15.52 $201,612 - $443,204	-28,557 Reduced 61.07%	18,202 $234,000
Q1 2022 Apr 27, 2022	SELL	$5.31 - $8.31 $21,962 - $34,370	-4,136 Reduced 8.13%	46,759 $388,000
Q4 2021 Jan 31, 2022	SELL	$5.21 - $7.45 $105,721 - $151,175	-20,292 Reduced 28.51%	50,895 $345,000
Q3 2021 Nov 03, 2021	SELL	$4.85 - $6.04 $48,800 - $60,774	-10,062 Reduced 12.38%	71,187 $377,000
Q1 2021 Apr 29, 2021	SELL	$3.45 - $4.69 $57,487 - $78,149	-16,663 Reduced 17.02%	81,249 $375,000
Q4 2020 Jan 28, 2021	SELL	$2.97 - $3.83 $21,701 - $27,985	-7,307 Reduced 6.94%	97,912 $327,000
Q3 2020 Oct 29, 2020	BUY	$2.97 - $5.08 $312,500 - $534,512	105,219 New	105,219 $313,000

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.